VRDN - CIK 0001590750
Viridian Therapeutics, Inc.DE (VRDN) reported revenue of $4.00M for fiscal year 2017, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2017 | $4.00M | +15.1% |
| FY 2016 | $3.48M | -39.1% |
| FY 2015 | $5.71M | -12.0% |
| FY 2014 | $6.48M | +50.2% |
| FY 2013 | $4.32M | - |
Viridian Therapeutics, Inc.DE (VRDN) reported revenue of $4.00M for fiscal year 2017, as filed in its audited annual report with the SEC.
Between fiscal 2013 and fiscal 2017, Viridian Therapeutics, Inc.DE's revenue declined from $4.32M to $4.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.